Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation: A prospective trial of tacrolimus immunesuppression with percutaneous biopsy

Annals of Surgery

Volumn 224, Issue 4, 1996, Pages 440-452

  Bartlett, Stephen T ^a   Schweitzer, Eugene J ^a   Johnson, Lynt B ^a   Kuo, Paul C ^a   Papadimitriou, John C ^a   Drachenberg, Cinthia B ^a   Klassen, David K ^a   Hoehn Saric, Edward W ^a   Weir, Matthew R ^a   Imbembo, Anthony L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY TRANSPLANTATION; MALE; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; BIOPSY, NEEDLE; CYCLOSPORINE; DIABETES MELLITUS, TYPE 1; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS; PANCREAS TRANSPLANTATION; PROSPECTIVE STUDIES; TACROLIMUS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 10144247895     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199610000-00003     Document Type: Article

References (33)

1. American Diabetes Association Position Statement. Pancreas transplantation for patients with diabetes mellitus. Diabetes Care 1993; 16:21.
2. Sutherland DER. Medicare coverage: pancreas transplantation Chimera 1991; 3:27.
3. Stratta RJ, Taylor RJ, Bynon JS, et al. Surgical treatment of diabetes mellitus with pancreas transplantation. Ann Surg 1994; 220:809-817.
4. Sutherland DER. International pancreas transplant registry. Presented at the Fifth Congress of the International Pancreas and Islet Transplant Association: June 18-22, 1995; Miami, FL.
5. Gruessner A, Sutherland DER. Pancreas transplant results in the UNOS United States of America Registry compared with nonUSA data in the international registry. In: Terasaki P, Cecka JM, eds. Clinical Transplants. Los Angeles, CA: UCLA Tissue Typing Laboratory; 1994:47-68.
6. Prieto M, Sutherland DER, Fernandez-Cruz L, et al. Urinary amylase monitoring for early diagnosis of pancreas allograft rejection in dogs. J Surg Res 1986; 40:597-604.
7. Benedetti E, Bajarian JS, Gruessner A, et al. Correlation between cystoscopic biopsy results and hypoamylasuria in bladder-drained pancreas transplants. Surgery 1995; 118:864-872.
8. Perkal M, Marks C, Lorber MI, Marks WH. A three-year experience with serum anodal trypsinogen as a biochemical marker for rejection in pancreatic allografts: false positives, tissue biopsy, comparison with other markers, and diagnostic strategies. Transplantation 1992; 53:415-419.
9. Johnson LB, Shatter D, McNally D, et al. Urinary trypsinogen activation peptides (TAP) signal proteolytic enzyme activation in recipients of pancreas allografts and predicts acute allograft rejection. Presented at the Fifth International Congress on Pancreas and Islet Transplantation; June 18-22, 1995; Miami, FL.
10. Krebs TL, Daly BD, Wong JJ, Bartlett ST. MR derived pancreas to psoas ration: objective and reliable non-invasive diagnosis of pancreatic rejection. International Pancreas Transplantation Association. Miami, FL, June 19, 1995.
11. Radio SJ, Stratt R, Taylor T, Linder J. The utility of urine cytology in the diagnosis of allograft rejection after combined pancreas-kidney transplantation. Transplantation 1993; 55:509-516.
12. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44:411-422.
13. Lowell J, Bynon JS, Nelson N, et al. Improved technique for transduodenal pancreas transplant biopsy. Transplantation 1994; 57:752-753.
14. Gaber AO, Gaber LW, Shokouh-Amiri MH, Hathaway D. Percutaneous biopsy of pancreas transplants. Transplantation 1992; 54:548.
15. Klassen D, Hoehn-Saric E, Weir M, et al. Isolated pancreas rejection in combined kidney pancreas transplantation. Transplantation 1996; 61:974-977.
16. Bartlett ST, dela Torre A, Johnson L, et al. Long term pancreatic function: potential benefits. Transplant Proc (in press).
17. Jordan ML, Shapiro R, Vivas CA, et al. FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation 1994; 57:860-865.
18. Gaber AO, Shokouh-Amiri MH, Hathaway DK, et al. Ann Surg 1995; 221:613-624.
19. Sollinger HW, The U.S. Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995; 60:225-232.
20. Wong JJ, Krebs TL, Klassen DK, et al. Sonographic evaluation of acute pancreatic transplant rejection: Morphology/Doppler analysis versus guided percutaneous biopsy. AJR Am J Roentgenol 1996; 166:803-807.
21. Nakhleh R, Gruessner R, Swanson P, et al. Pancreas transplant pathology: a morphologic, immunohistochemical, and electron microscopic comparison of allogeneic grafts with rejection, syngeneic grafts, and chronic pancreatitis. Am J Surg Pathol 1991; 15:246-256.
22. Nakhleh R, Sutherland DER. Pancreas rejection: significance of histopathologic findings with implications for classification of rejection. Am J Surg Pathol 1992; 16:1098-1107.
23. Drachenberg C, Klassen D, Bartlett S, et al. Histologic grading of pancreas acute allograft rejection in percutaneous needle biopsies. Transplant Proc 1996; 28:512-513.
24. European FK506 Multicentre Liver Study Group. Randomized trail comparing tacrolimus(FK 506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994; 344:423-428.
25. The U.S. Multicenter FK506 Liver Study Group. A comparison of tacrolimus(FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994; 331:1110-1115.
26. Gruessner R, Burke G, Stratta R, et al. A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. Transplantation 1996; 61:261-273.
27. Gruessner R, Nakhleh R, Tzardis P, et al. Differences in rejection grading after simultaneous pancreas and kidney transplantation in pigs. Transplantation 1994; 57:1021-1028.
28. Nakhleh R, Sutherland DER, Tzardis P, et al. Correlation of rejection of the duodenum with rejection of the pancreas in a pig model of pancreaticoduodenal transplantation. Transplantation 1993; 56:1353-1356.
29. Gruessner RWG, Nakhleh R, Tzardis P, et al. Rejection patterns after simultaneous pancreaticoduodenal-kidney transplants in pigs. Transplantation 1994; 57:756-760.
30. Gruessner RWG, Nakhleh R, Tzardis P, et al. Rejection in single versus combined pancreas and kidney transplantation in pigs. Transplantation 1993; 56:1053-1062.
31. Nakhleh R, Benedetti E, Gruessner A, et al. Cystoscopic biopsies in pancreaticoduodenal transplantation: are duodenal biopsies indicative of pancreas dysfunction? Transplantation 1995; 60:541-546.
32. Kuhr CS, Davis CL, Barr D, et al. Use of ultrasound and cystoscopically guided pancreatic allograft biopsies and transabdominal renal allograft biopsies: safety and efficacy in kidney-pancreas transplant recipients. J Urol 1995; 153:316-321.
33. Troppmann C, Gruessner AC, Benedetti E, et al. Vascular graft thrombosis after pancreatic transplantation: univariate and multivariate operative and nonoperative risk factor analysis. J Am Coll Surg 1996; 182:285-316.